Header Logo

Connection

Mohammed Tikly to Methotrexate

This is a "connection" page, showing publications Mohammed Tikly has written about Methotrexate.
Connection Strength

0,626
  1. Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol. 2012 Apr; 31(4):613-9.
    View in: PubMed
    Score: 0,391
  2. Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2019 01 01; 58(1):149-153.
    View in: PubMed
    Score: 0,160
  3. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2000 Jun; 39(6):655-65.
    View in: PubMed
    Score: 0,044
  4. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord. 2015 May 29; 16:130.
    View in: PubMed
    Score: 0,031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.